Publications by authors named "Marc Padrines"

Claim this Profile
A
A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis.
Steven Georges, Julie Chesneau, Soizic Hervouet, Julien Taurelle, François Gouin, Marc Padrines

Eur J Cancer· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulatory effects of proteoglycans on proteinase activities.
Steven Georges, Dominique Heymann, Marc Padrines

Methods Mol Biol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteoglycans and osteolysis.
Marc Baud'Huin, Céline Charrier, Gwenola Bougras, Régis Brion, Frédéric Lezot, Marc Padrines

Methods Mol Biol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Tumor Necrosis Factor α, Parathyroid Hormone, and Vitamin D3 on Modulation of the RANKL2 Isoform: A Pilot Study.
Steeve Kwan Tat, Jean-Pierre Pelletier, Carmen Ruiz-Velasco, Marc Padrines, Yannick Fortun

Cartilage· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption.
Marc Baud'huin, Carmen Ruiz-Velasco, Gaëtan Jego, Céline Charrier, Nijole Gasiunas, Marc Padrines

Eur J Cell Biol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteoglycans on bone tumor development.
Carmen Ruiz Velasco, Sylvia Colliec-Jouault, Françoise Redini, Dominique Heymann, Marc Padrines

Drug Discov Today· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?
Steeve Kwan Tat, Jean-Pierre Pelletier, Carmen Ruiz Velasco, Marc Padrines, Johanne Martel-Pelletier

Keio J Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation.
Steeve Kwan Tat, Marc Padrines, Sandrine Theoleyre, Severine Couillaud-Battaglia, Dominique Heymann

Bone· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteolytic bone diseases: physiological analogues of bone resorption effectors as alternative therapeutic tools.
Dominique Heymann, Yannick Fortun, Francoise Rédini, Marc Padrines

Drug Discov Today· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology.
Steeve Kwan Tat, Marc Padrines, Sandrine Théoleyre, Dominique Heymann, Yannick Fortun

Cytokine Growth Factor Rev· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis